As we see out September, it’s good to look at what is imminent. During October/November I expect the signing of the US agreement and the FDA approval. Please add to these:
- AZD0466 to commence clinical trials in FY19 (from p.18 SPL annual report). Patent application subsequently published and announced 31 August 2018
- Dep irinotecan to commence clinical trials and final preclinical work underway in preparation (p.15 annual report)
- FDA approval 6-8 months from submission date on 30 April 2018.
- Announcement of US vivagel distributor, described as in “advanced negotiations” on p3 of the annual report.
- further DEP portfolio milestones in the year ahead (again from page 2 of the annual report).
- Forums
- ASX - By Stock
- SPL
- News for October and November
News for October and November
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.7¢ |
Change
0.001(1.04%) |
Mkt cap ! $39.58M |
Open | High | Low | Value | Volume |
9.7¢ | 9.8¢ | 9.4¢ | $31.39K | 321.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 59000 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 103527 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 59000 | 0.095 |
2 | 99465 | 0.094 |
1 | 100000 | 0.093 |
1 | 100000 | 0.092 |
1 | 49413 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 103527 | 4 |
0.098 | 136 | 1 |
0.099 | 164163 | 3 |
0.100 | 162106 | 5 |
0.105 | 116531 | 4 |
Last trade - 12.23pm 29/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |